Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.1K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.1K
Intellectual Disability01:29

Intellectual Disability

1.0K
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
1.0K
Dementia01:30

Dementia

672
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
672
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

813
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
813
Language and Cognition01:27

Language and Cognition

939
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
939

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypertrophic Cardiomyopathy and Sudden Cardiac Arrest Associated with a PSEN1 Variant: A Case Report.

Internal medicine (Tokyo, Japan)·2026
Same author

Eligibility for Anti-Amyloid-β Monoclonal Antibodies in Patients With Primary Progressive Aphasia due to Alzheimer's Disease in Japan.

Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society·2026
Same author

Prospective study on clinical utility of plasma p-Tau217 and other biomarkers in Japanese memory clinics using the LUMIPULSE platform.

Alzheimer's research & therapy·2026
Same author

Evaluation of the effects of lecanemab treatment on brain atrophy using voxel-based specific regional analysis system for Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Related Experiment Video

Updated: Mar 23, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

[Mild cognitive impairment].

Soichiro Shimizu, Haruo Hanyu

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |March 31, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Mild cognitive impairment (MCI) is a transitional stage to dementia. Certain MCI subtypes, particularly amnestic MCI, indicate a high risk for Alzheimer's disease progression, showing specific brain perfusion patterns.

    More Related Videos

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
    06:23

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

    Published on: October 13, 2016

    34.1K
    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
    07:42

    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

    Published on: December 16, 2022

    3.9K

    Related Experiment Videos

    Last Updated: Mar 23, 2026

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    8.2K
    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
    06:23

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

    Published on: October 13, 2016

    34.1K
    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
    07:42

    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

    Published on: December 16, 2022

    3.9K

    Area of Science:

    • Neurology
    • Neuroscience
    • Geriatrics

    Background:

    • Mild cognitive impairment (MCI) represents a critical transitional phase between normal cognition and dementia.
    • MCI subtypes exhibit significant heterogeneity in causes, clinical manifestations, and outcomes.
    • The amnestic subtype of MCI is strongly associated with an elevated risk of progressing to Alzheimer's disease (AD), potentially signifying its prodromal stage.

    Purpose of the Study:

    • To review the current understanding of Mild Cognitive Impairment (MCI).
    • To discuss the clinical presentation and diagnostic indicators of MCI.
    • To highlight the association between specific MCI subtypes and Alzheimer's disease progression.

    Main Methods:

    • Literature review of current research on Mild Cognitive Impairment (MCI).
    • Analysis of studies examining the relationship between MCI subtypes and Alzheimer's disease (AD).
    • Discussion of neuroimaging findings, such as single-photon emission computed tomography (SPECT) in MCI patients.

    Main Results:

    • Patients with amnestic MCI face a heightened risk of developing Alzheimer's disease (AD).
    • Parietotemporal hypoperfusion on SPECT scans in unaware MCI patients without practice effects predicts AD progression.
    • MCI is a heterogeneous condition with varying etiologies and prognoses.

    Conclusions:

    • MCI is a significant precursor to dementia, especially Alzheimer's disease.
    • Identifying specific MCI subtypes and neuroimaging markers can aid in predicting AD progression.
    • Understanding MCI's concept and clinical presentation is crucial for early diagnosis and intervention.